TY  - GEN
AU  - Conroy,T
AU  - Cappelaere,P
AU  - Fabbro,M
AU  - Fauser,A A
AU  - Splinter,T A
AU  - Spielmann,M
AU  - Schneider,M
AU  - Chevallier,B
AU  - Goupil,A
AU  - Chauvergne,J
TI  - Acute antiemetic efficacy and safety of dolasetron mesylate, a 5-HT3 antagonist, in cancer patients treated with cisplatin. European Dolasetron Study Group
SN  - 0277-3732
PY  - 1994///0428
KW  - Adult
KW  - Aged
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - therapeutic use
KW  - Cisplatin
KW  - administration & dosage
KW  - Female
KW  - Humans
KW  - Indoles
KW  - adverse effects
KW  - Male
KW  - Middle Aged
KW  - Nausea
KW  - chemically induced
KW  - Neoplasms
KW  - drug therapy
KW  - Quinolizines
KW  - Serotonin Antagonists
KW  - Treatment Outcome
KW  - Vomiting
N1  - Publication Type: Journal Article
UR  - https://doi.org/10.1097/00000421-199404000-00002
ER  -